Potentiation of human polymorphonuclear leukocytes respiratory burst and phagocytosis by a standardized liver and spleen fraction of peptides

R. Cramer, P. Dri, P. Spessotto, H. Mittenzwei, P. Patriarca

Research output: Contribution to journalArticlepeer-review

Abstract

The effect of Factor AF2® (AF2), a xenogeneic fraction of peptides with a molecular weight of <10000 Dalton obtained from livers and spleens of newborn lambs, on the oxygen consumption and the phagocytic activity of human polymorphonuclear leukocytes (PMN) was studied. AF2 increased the oxygen uptake of PMN exposed both to serum-treated zymosan (STZ), a phagocytosable stimulus, and phorbol-myristate-acetate (PMA), a soluble stimulus. The potentiating effect of the drug was dose-dependent and more pronounced when suboptimal amounts of either stimulus were used. The phagocytic activity of PMN, as measured by the rate of mineral oil particles ingestion, was also increased by AF2 in a dose-dependent manner. These results suggest that the drug may influence PMN behaviour in at least two ways: 1. by increasing the rate of phagocytosis, and 2. by potentiating the respiratory burst induced by soluble and particulate stimuli. The results are discussed in relation to the beneficial effects of AF2 in cancer patients under chemotherapy or radiation treatment.

Original languageEnglish
Pages (from-to)686-689
Number of pages4
JournalArzneimittel-Forschung/Drug Research
Volume43
Issue number6
Publication statusPublished - 1993

Keywords

  • factor AF2®
  • immunomodulators
  • peptide fraction
  • polymorphonuclear leukocytes
  • respiratory burst

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Fingerprint Dive into the research topics of 'Potentiation of human polymorphonuclear leukocytes respiratory burst and phagocytosis by a standardized liver and spleen fraction of peptides'. Together they form a unique fingerprint.

Cite this